#  @Muralidharan125 Muralidharan Alagarraj Muralidharan Alagarraj posts on X about $cadl, fda, in the, this is the most. They currently have [---] followers and [--] posts still getting attention that total [---] engagements in the last [--] hours. ### Engagements: [---] [#](/creator/twitter::137679081/interactions)  - [--] Week [---] +163% - [--] Month [-----] +75% - [--] Months [------] +229% - [--] Year [------] -50% ### Mentions: [--] [#](/creator/twitter::137679081/posts_active)  ### Followers: [---] [#](/creator/twitter::137679081/followers)  - [--] Week [---] no change - [--] Year [---] +34% ### CreatorRank: undefined [#](/creator/twitter::137679081/influencer_rank)  ### Social Influence **Social category influence** [stocks](/list/stocks) [finance](/list/finance) [financial services](/list/financial-services) [countries](/list/countries) [technology brands](/list/technology-brands) [social networks](/list/social-networks) [cryptocurrencies](/list/cryptocurrencies) [celebrities](/list/celebrities) **Social topic influence** [$cadl](/topic/$cadl) #6, [fda](/topic/fda), [in the](/topic/in-the), [this is](/topic/this-is), [comments](/topic/comments), [company](/topic/company), [$catx](/topic/$catx), [opportunity](/topic/opportunity), [paul](/topic/paul), [legends](/topic/legends) **Top accounts mentioned or mentioned by** [@pharmdca](/creator/undefined) [@paulpetertak](/creator/undefined) [@globalgenes](/creator/undefined) [@coldsouppppp](/creator/undefined) [@biopharmiq](/creator/undefined) [@jacobplieth](/creator/undefined) [@gurgavin](/creator/undefined) [@bagelc47](/creator/undefined) [@nataninvesting](/creator/undefined) [@beckpete](/creator/undefined) [@ashton1nvests](/creator/undefined) [@fbjb816](/creator/undefined) [@maximusholla](/creator/undefined) [@stockmktnewz](/creator/undefined) [@danw2capital](/creator/undefined) [@apexonco](/creator/undefined) [@williamblair](/creator/undefined) [@candeltxs](/creator/undefined) [@elonmusk](/creator/undefined) **Top assets mentioned** [Candel Therapeutics, Inc. (CADL)](/topic/$cadl) [Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [BlackRock Inc (BLK)](/topic/blackrock) [Microsoft Corp. (MSFT)](/topic/microsoft) [Alphabet Inc Class A (GOOGL)](/topic/$googl) [Eli Lilly and Company (LLY)](/topic/$lly) ### Top Social Posts Top posts by engagements in the last [--] hours "@gurgavin Why they used google meets instead of Microsoft teams" [X Link](https://x.com/Muralidharan125/status/1726182249065001126) 2023-11-19T10:14Z [---] followers, [--] engagements "@Pharmdca Whats your target for $DAWN $30" [X Link](https://x.com/Muralidharan125/status/1861452076368232951) 2024-11-26T16:48Z [---] followers, [---] engagements "@Pharmdca Sanjit ji $CADL" [X Link](https://x.com/Muralidharan125/status/1863790307877249127) 2024-12-03T03:40Z [---] followers, [---] engagements "@coldsouppppp @BiopharmIQ @Pharmdca wondering when the world will understand how big this is . Soon. $CADL" [X Link](https://x.com/Muralidharan125/status/1865100445678436717) 2024-12-06T18:26Z [---] followers, [---] engagements "@Pharmdca Not a recommendation. Whats $VKTX to you is $CADL to me ji 🙏" [X Link](https://x.com/Muralidharan125/status/1865106773750710294) 2024-12-06T18:51Z [---] followers, [---] engagements "@coldsouppppp @BiopharmIQ @Pharmdca All worked out 💪" [X Link](https://x.com/Muralidharan125/status/1866850162808598822) 2024-12-11T14:18Z [---] followers, [--] engagements "@Pharmdca Good morning Sanjit ji. I have learnt a lot from you regarding investing . Discipline believing in science ignoring short term noises and doubling down on pull backs etc etc . I would like your thoughts on $CADL when you have some time . They had great Ph3 prostate results🙏" [X Link](https://x.com/Muralidharan125/status/1867180055144645035) 2024-12-12T12:09Z [---] followers, [---] engagements "@BagelC47 Candel Therapeutics Announces Pricing of Public Offering Candel Therapeutics Inc" [X Link](https://x.com/Muralidharan125/status/1867425761306849302) 2024-12-13T04:26Z [---] followers, [--] engagements "@nataninvesting $CADL approved phase [--] for prostate cancer successful phase [--] for NSCLC and pancreatic cancer successful phase 1b for high grade glioma; Special protocol assessment (SPA) fast track orphan drug designation from fda and orphan drug designation from EMA 👏👏👏" [X Link](https://x.com/Muralidharan125/status/1949119835436101771) 2025-07-26T14:49Z [---] followers, [---] engagements "$CADL @CandelTx $CADL appears significantly undervalued. Management recently bought $7.1 million of stock. Its lead asset achieved statistically significant Phase [--] results under an FDA SPA in a $10 billion market and was highlighted at ASCO. Cash runway extends to Q1 [----]. Two additional $CADL appears significantly undervalued. Management recently bought $7.1 million of stock. Its lead asset achieved statistically significant Phase [--] results under an FDA SPA in a $10 billion market and was highlighted at ASCO. Cash runway extends to Q1 [----]. Two additional" [X Link](https://x.com/anyuser/status/1949131575284670826) 2025-07-26T15:35Z [---] followers, [---] engagements "@beck_pete @Ashton_1nvests $CADL no brainer imho" [X Link](https://x.com/Muralidharan125/status/1949861842181836903) 2025-07-28T15:57Z [---] followers, [--] engagements "$CADL indeed a table pounding buy opportunity $CADL Dr. Paul Peter Taks comments Couldnt have said it any better I think this is a table pounding buy opportunity. https://t.co/bPy3nr48tD $CADL Dr. Paul Peter Taks comments Couldnt have said it any better I think this is a table pounding buy opportunity. https://t.co/bPy3nr48tD" [X Link](https://x.com/anyuser/status/1955081016776753633) 2025-08-12T01:36Z [---] followers, [---] engagements "@fbjb816 $CATX" [X Link](https://x.com/Muralidharan125/status/1959212308703727842) 2025-08-23T11:13Z [---] followers, [--] engagements "$CADL @CandelTx .@paulpetertak @CandelTx discusses the company's viral immunotherapy for brain cancer how it works and what clinical studies have shown to date. @GlobalGenes #RARECast https://t.co/DsMOSFXLZf https://t.co/kBM3QDD0ut .@paulpetertak @CandelTx discusses the company's viral immunotherapy for brain cancer how it works and what clinical studies have shown to date. @GlobalGenes #RARECast https://t.co/DsMOSFXLZf https://t.co/kBM3QDD0ut" [X Link](https://x.com/anyuser/status/1969197245359595642) 2025-09-20T00:29Z [---] followers, [---] engagements "$CADL Did you that CAN-2409 has SPA Fast Track and RMAT from FDA for Prostate cancer @CandelTx https://www.pharmanow.live/latest-news/fda-rmat-designation-can-2409 https://www.pharmanow.live/latest-news/fda-rmat-designation-can-2409" [X Link](https://x.com/anyuser/status/1974429417112998251) 2025-10-04T11:00Z [---] followers, [---] engagements "$CADL https://ir.candeltx.com/news-releases/news-release-details/candel-therapeutics-host-virtual-rd-event-december-5-2025 https://ir.candeltx.com/news-releases/news-release-details/candel-therapeutics-host-virtual-rd-event-december-5-2025" [X Link](https://x.com/anyuser/status/1990572127398080669) 2025-11-18T00:05Z [---] followers, [---] engagements "@Maximus_Holla $CATX" [X Link](https://x.com/Muralidharan125/status/1992001935273312602) 2025-11-21T22:47Z [---] followers, [---] engagements "@Pharmdca $cadl" [X Link](https://x.com/Muralidharan125/status/2004396480103436579) 2025-12-26T03:38Z [---] followers, [---] engagements "@StockMKTNewz $CADL" [X Link](https://x.com/Muralidharan125/status/2006425369386352943) 2025-12-31T18:01Z [---] followers, [---] engagements "Blackrock 5.2% stake $CADL @CandelTx #ICYMI - Our Virtual R&D Day brought together immunotherapy legends alongside leading oncologists to discuss our viral immunotherapy platform CAN-2409s path to BLA submission and updates across our clinical pipeline. Watch the full webcast https://t.co/BOauAYuC0J $CADL https://t.co/WPJNefgDuZ #ICYMI - Our Virtual R&D Day brought together immunotherapy legends alongside leading oncologists to discuss our viral immunotherapy platform CAN-2409s path to BLA submission and updates across our clinical pipeline. Watch the full webcast https://t.co/BOauAYuC0J" [X Link](https://x.com/anyuser/status/2014034026135241145) 2026-01-21T17:55Z [---] followers, [---] engagements "@DanW2Capital https://ir.candeltx.com/news-releases/news-release-details/candel-therapeutics-host-virtual-rd-event-december-5-2025 https://ir.candeltx.com/news-releases/news-release-details/candel-therapeutics-host-virtual-rd-event-december-5-2025" [X Link](https://x.com/Muralidharan125/status/1990571980417036487) 2025-11-18T00:05Z [---] followers, [--] engagements "$CADL Candel Therapeutics Isnt Just a Science Fair Anymore @CandelTx $CADL Candel Therapeutics Inc. (NASDAQ:CADL) is one of those small-caps that can flip the narrative fastbecause its not pitching theory. Its lead program has reported Phase [--] prostate cancer results with a statistically significant endpoint win and the company is pointing to $CADL Candel Therapeutics Inc. (NASDAQ:CADL) is one of those small-caps that can flip the narrative fastbecause its not pitching theory. Its lead program has reported Phase [--] prostate cancer results with a statistically significant endpoint win and the" [X Link](https://x.com/anyuser/status/2022754776522363251) 2026-02-14T19:28Z [---] followers, [--] engagements "$CADL Candel Therapeutics Isnt Just a Science Fair Anymore @CandelTx $CADL Candel Therapeutics Inc. (NASDAQ:CADL) is one of those small-caps that can flip the narrative fastbecause its not pitching theory. Its lead program has reported Phase [--] prostate cancer results with a statistically significant endpoint win and the company is pointing to $CADL Candel Therapeutics Inc. (NASDAQ:CADL) is one of those small-caps that can flip the narrative fastbecause its not pitching theory. Its lead program has reported Phase [--] prostate cancer results with a statistically significant endpoint win and the" [X Link](https://x.com/anyuser/status/2022754776522363251) 2026-02-14T19:28Z [---] followers, [--] engagements "$CADL Candel Therapeutics Inc. (NASDAQ:CADL) is one of those small-caps that can flip the narrative fastbecause its not pitching theory. Its lead program has reported Phase [--] prostate cancer results with a statistically significant endpoint win and the company is pointing to a clear regulatory runway that investors can actually calendar. https://biotechhealthx.com/biotech-news/the-290m-cancer-biotech-with-phase-3-proof-candel-cadls-viral-immunotherapy-isnt-just-a-science-fair-anymore/" [X Link](https://x.com/anyuser/status/2022529456926265594) 2026-02-14T04:32Z [---] followers, [---] engagements "Blackrock 5.2% stake $CADL @CandelTx #ICYMI - Our Virtual R&D Day brought together immunotherapy legends alongside leading oncologists to discuss our viral immunotherapy platform CAN-2409s path to BLA submission and updates across our clinical pipeline. Watch the full webcast https://t.co/BOauAYuC0J $CADL https://t.co/WPJNefgDuZ #ICYMI - Our Virtual R&D Day brought together immunotherapy legends alongside leading oncologists to discuss our viral immunotherapy platform CAN-2409s path to BLA submission and updates across our clinical pipeline. Watch the full webcast https://t.co/BOauAYuC0J" [X Link](https://x.com/anyuser/status/2014034026135241145) 2026-01-21T17:55Z [---] followers, [---] engagements "#ICYMI - Our Virtual R&D Day brought together immunotherapy legends alongside leading oncologists to discuss our viral immunotherapy platform CAN-2409s path to BLA submission and updates across our clinical pipeline. Watch the full webcast $CADL https://ir.candeltx.com/events/event-details/candel-therapeutics-host-virtual-rd-event https://ir.candeltx.com/events/event-details/candel-therapeutics-host-virtual-rd-event" [X Link](https://x.com/anyuser/status/2013990172803604612) 2026-01-21T15:00Z [---] followers, [----] engagements "Should be $10 by EOY $CATX Target price: $2.70 Perspective Therapeutics Inc. is a medical technology and radiopharmaceutical company which engages in the provision of treatment applications for cancers. https://t.co/kMv7qvH62A $CATX Target price: $2.70 Perspective Therapeutics Inc. is a medical technology and radiopharmaceutical company which engages in the provision of treatment applications for cancers. https://t.co/kMv7qvH62A" [X Link](https://x.com/anyuser/status/2007427193329074232) 2026-01-03T12:21Z [---] followers, [--] engagements "$CATX Target price: $2.70 Perspective Therapeutics Inc. is a medical technology and radiopharmaceutical company which engages in the provision of treatment applications for cancers" [X Link](https://x.com/anyuser/status/1993311645532356731) 2025-11-25T13:31Z [----] followers, [----] engagements "$CADL https://ir.candeltx.com/news-releases/news-release-details/candel-therapeutics-host-virtual-rd-event-december-5-2025 https://ir.candeltx.com/news-releases/news-release-details/candel-therapeutics-host-virtual-rd-event-december-5-2025" [X Link](https://x.com/anyuser/status/1990572127398080669) 2025-11-18T00:05Z [---] followers, [---] engagements "$CADL Did you that CAN-2409 has SPA Fast Track and RMAT from FDA for Prostate cancer @CandelTx https://www.pharmanow.live/latest-news/fda-rmat-designation-can-2409 https://www.pharmanow.live/latest-news/fda-rmat-designation-can-2409" [X Link](https://x.com/anyuser/status/1974429417112998251) 2025-10-04T11:00Z [---] followers, [---] engagements "$CADL @CandelTx .@paulpetertak @CandelTx discusses the company's viral immunotherapy for brain cancer how it works and what clinical studies have shown to date. @GlobalGenes #RARECast https://t.co/DsMOSFXLZf https://t.co/kBM3QDD0ut .@paulpetertak @CandelTx discusses the company's viral immunotherapy for brain cancer how it works and what clinical studies have shown to date. @GlobalGenes #RARECast https://t.co/DsMOSFXLZf https://t.co/kBM3QDD0ut" [X Link](https://x.com/anyuser/status/1969197245359595642) 2025-09-20T00:29Z [---] followers, [---] engagements ".@paulpetertak @CandelTx discusses the company's viral immunotherapy for brain cancer how it works and what clinical studies have shown to date. @GlobalGenes #RARECast https://globalgenes.org/raredaily/650370/ https://globalgenes.org/raredaily/650370/" [X Link](https://x.com/anyuser/status/1969108875539321157) 2025-09-19T18:38Z [----] followers, [----] engagements "RT @paulpetertak: I really appreciate your response @JacobPlieth. Debating helps in the context of truth-seeking and X is a good platform" [X Link](https://x.com/anyuser/status/1966627565910524155) 2025-09-12T22:18Z [---] followers, [--] engagements "I really appreciate your response @JacobPlieth. Debating helps in the context of truth-seeking and X is a good platform to do so. Engaging in constructive debate is great and I want to thank you for this. Moving forward I will be happy to answer any questions and provide context before you publish your own independent views based on the facts provided. In fact I am looking forward to working with you. Based on the specific points you made earlier this week for example about the validity of the SPA and the lack of ITT analysis (both comments were erroneous) it appeared that these were" [X Link](https://x.com/anyuser/status/1966478794278990279) 2025-09-12T12:27Z [----] followers, [----] engagements ""The comments about the SPA are also completely wrong and misleading as Candel has strictly adhered to the agreement with the FDA and the SPA is intact" From $CADL [--] Nov [----] SEC filing (8/8)" [X Link](https://x.com/anyuser/status/1966099427057348868) 2025-09-11T11:20Z 31.8K followers, [----] engagements "Impressive to get so many things wrong in one report by Jacob Plieth from @ApexOnco . [--]. The name of CAN-2409 is aglatimagene besadenovec not agla-vec. [--]. The data of the phase 2a clinical trial of CAN-240 in NSCLC has never disappointed. They are in fact very encouraging reason why the presentation by Professor Charu Aggarwal was selected for oral presentation at World Lung [----] and why Candel recently had a very constructive end of phase [--] meeting with the FDA. This data also resulted in Fast Track Designation from the FDA; the promising overall survival data got even stronger after" [X Link](https://x.com/anyuser/status/1965895493721931830) 2025-09-10T21:49Z [----] followers, 13.9K engagements ": @WilliamBlair Senior Biotech Analyst Andy Hsieh reacts to today's oral obesity data from Viking's VK2735 and recent data from Lilly's orforglipron. $VKTX $LLY Full video: https://www.biotechtv.com/post/andy-hsieh-vk2735-august-19-2025 https://www.biotechtv.com/post/andy-hsieh-vk2735-august-19-2025" [X Link](https://x.com/anyuser/status/1957917099961303073) 2025-08-19T21:26Z 10.7K followers, 68.5K engagements "$CADL indeed a table pounding buy opportunity $CADL Dr. Paul Peter Taks comments Couldnt have said it any better I think this is a table pounding buy opportunity. https://t.co/bPy3nr48tD $CADL Dr. Paul Peter Taks comments Couldnt have said it any better I think this is a table pounding buy opportunity. https://t.co/bPy3nr48tD" [X Link](https://x.com/anyuser/status/1955081016776753633) 2025-08-12T01:36Z [---] followers, [---] engagements "$CADL Dr. Paul Peter Taks comments Couldnt have said it any better I think this is a table pounding buy opportunity" [X Link](https://x.com/anyuser/status/1944913988397228222) 2025-07-15T00:16Z [---] followers, [----] engagements "$CADL @CandelTx $CADL appears significantly undervalued. Management recently bought $7.1 million of stock. Its lead asset achieved statistically significant Phase [--] results under an FDA SPA in a $10 billion market and was highlighted at ASCO. Cash runway extends to Q1 [----]. Two additional $CADL appears significantly undervalued. Management recently bought $7.1 million of stock. Its lead asset achieved statistically significant Phase [--] results under an FDA SPA in a $10 billion market and was highlighted at ASCO. Cash runway extends to Q1 [----]. Two additional" [X Link](https://x.com/anyuser/status/1949131575284670826) 2025-07-26T15:35Z [---] followers, [---] engagements "$CADL appears significantly undervalued. Management recently bought $7.1 million of stock. Its lead asset achieved statistically significant Phase [--] results under an FDA SPA in a $10 billion market and was highlighted at ASCO. Cash runway extends to Q1 [----]. Two additional programs are moving toward Phase [--] with non-dilutive funding. A grant-backed rHGG asset has promising data due later this year. Analyst price targets cluster around $20 $25 per share. What an opportunity" [X Link](https://x.com/anyuser/status/1944880650852687920) 2025-07-14T22:04Z [----] followers, [----] engagements ": @CandelTx's CEO @paulpetertak describes phase [--] prostate cancer data from the company's off-the-shelf adeno delivered cancer immunotherapy. #ASCO25 $CADL Full video: https://www.biotechtv.com/post/candel-therapeutics-asco-2025 https://www.biotechtv.com/post/candel-therapeutics-asco-2025" [X Link](https://x.com/anyuser/status/1929688360614089196) 2025-06-02T23:55Z 10.7K followers, [----] engagements "$CADL https://www.biotechtv.com/post/the-studio-at-kendall-square-paul-peter-tak-mike-rea https://www.biotechtv.com/post/the-studio-at-kendall-square-paul-peter-tak-mike-rea" [X Link](https://x.com/anyuser/status/1907253814446485688) 2025-04-02T02:08Z [---] followers, [---] engagements "We're pleased to share recent coverage highlighting our phase 2b and phase [--] prostate cancer clinical trials and anticipated data readouts. These trials represent key milestones as we advance novel treatments for cancer patients. $CADL https://www.proactiveinvestors.com/companies/news/1061802/candel-therapeutics-is-pushing-for-a-paradigm-shift-in-cancer-treatment-1061802.html https://www.proactiveinvestors.com/companies/news/1061802/candel-therapeutics-is-pushing-for-a-paradigm-shift-in-cancer-treatment-1061802.html" [X Link](https://x.com/CandelTx/status/1865063768943697935) 2024-12-06T16:00Z [---] followers, [----] engagements "Join me in NC State Day of Giving [----] https://dayofgiving.ncsu.edu https://dayofgiving.ncsu.edu" [X Link](https://x.com/anyuser/status/1770634345570512907) 2024-03-21T02:11Z [---] followers, [---] engagements "RT @elonmusk: While it is trivial to enter the United States illegally it is insanely difficult for legal immigrants to move to the United" [X Link](https://x.com/anyuser/status/1743073814815162403) 2024-01-05T00:55Z [---] followers, 26.8K engagements "While it is trivial to enter the United States illegally it is insanely difficult for legal immigrants to move to the United States. This is madness We should shut down illegal immigration and greatly increase legal immigration. This chart should make you go insane. This is the number of high skilled workers that want to work here. There is a cap at [-----] slots that will be filled. We are actively shooting our future selves in the foot. https://t.co/kYA8BDhzHC This chart should make you go insane. This is the number of high skilled workers that want to work here. There is a cap at [-----] slots" [X Link](https://x.com/anyuser/status/1742964379014860804) 2024-01-04T17:41Z 234.7M followers, 23.8M engagements "This chart should make you go insane. This is the number of high skilled workers that want to work here. There is a cap at [-----] slots that will be filled. We are actively shooting our future selves in the foot" [X Link](https://x.com/anyuser/status/1742946195893559482) 2024-01-04T16:28Z 2.5M followers, 22.4M engagements "Join me in #GivingPack https://dayofgiving.ncsu.edu https://dayofgiving.ncsu.edu" [X Link](https://x.com/anyuser/status/1506640230643908612) 2022-03-23T14:33Z [---] followers, [--] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
@Muralidharan125 Muralidharan Alagarraj
Muralidharan Alagarraj posts on X about $cadl, fda, in the, this is the most. They currently have [---] followers and [--] posts still getting attention that total [---] engagements in the last [--] hours.
Engagements: [---] #
- [--] Week [---] +163%
- [--] Month [-----] +75%
- [--] Months [------] +229%
- [--] Year [------] -50%
Mentions: [--] #
Followers: [---] #
- [--] Week [---] no change
- [--] Year [---] +34%
CreatorRank: undefined #
Social Influence
Social category influence stocks finance financial services countries technology brands social networks cryptocurrencies celebrities
Social topic influence $cadl #6, fda, in the, this is, comments, company, $catx, opportunity, paul, legends
Top accounts mentioned or mentioned by @pharmdca @paulpetertak @globalgenes @coldsouppppp @biopharmiq @jacobplieth @gurgavin @bagelc47 @nataninvesting @beckpete @ashton1nvests @fbjb816 @maximusholla @stockmktnewz @danw2capital @apexonco @williamblair @candeltxs @elonmusk
Top assets mentioned Candel Therapeutics, Inc. (CADL) Viking Therapeutics, Inc (VKTX) BlackRock Inc (BLK) Microsoft Corp. (MSFT) Alphabet Inc Class A (GOOGL) Eli Lilly and Company (LLY)
Top Social Posts
Top posts by engagements in the last [--] hours
"@gurgavin Why they used google meets instead of Microsoft teams"
X Link 2023-11-19T10:14Z [---] followers, [--] engagements
"@Pharmdca Whats your target for $DAWN $30"
X Link 2024-11-26T16:48Z [---] followers, [---] engagements
"@Pharmdca Sanjit ji $CADL"
X Link 2024-12-03T03:40Z [---] followers, [---] engagements
"@coldsouppppp @BiopharmIQ @Pharmdca wondering when the world will understand how big this is . Soon. $CADL"
X Link 2024-12-06T18:26Z [---] followers, [---] engagements
"@Pharmdca Not a recommendation. Whats $VKTX to you is $CADL to me ji 🙏"
X Link 2024-12-06T18:51Z [---] followers, [---] engagements
"@coldsouppppp @BiopharmIQ @Pharmdca All worked out 💪"
X Link 2024-12-11T14:18Z [---] followers, [--] engagements
"@Pharmdca Good morning Sanjit ji. I have learnt a lot from you regarding investing . Discipline believing in science ignoring short term noises and doubling down on pull backs etc etc . I would like your thoughts on $CADL when you have some time . They had great Ph3 prostate results🙏"
X Link 2024-12-12T12:09Z [---] followers, [---] engagements
"@BagelC47 Candel Therapeutics Announces Pricing of Public Offering Candel Therapeutics Inc"
X Link 2024-12-13T04:26Z [---] followers, [--] engagements
"@nataninvesting $CADL approved phase [--] for prostate cancer successful phase [--] for NSCLC and pancreatic cancer successful phase 1b for high grade glioma; Special protocol assessment (SPA) fast track orphan drug designation from fda and orphan drug designation from EMA 👏👏👏"
X Link 2025-07-26T14:49Z [---] followers, [---] engagements
"$CADL @CandelTx $CADL appears significantly undervalued. Management recently bought $7.1 million of stock. Its lead asset achieved statistically significant Phase [--] results under an FDA SPA in a $10 billion market and was highlighted at ASCO. Cash runway extends to Q1 [----]. Two additional $CADL appears significantly undervalued. Management recently bought $7.1 million of stock. Its lead asset achieved statistically significant Phase [--] results under an FDA SPA in a $10 billion market and was highlighted at ASCO. Cash runway extends to Q1 [----]. Two additional"
X Link 2025-07-26T15:35Z [---] followers, [---] engagements
"@beck_pete @Ashton_1nvests $CADL no brainer imho"
X Link 2025-07-28T15:57Z [---] followers, [--] engagements
"$CADL indeed a table pounding buy opportunity $CADL Dr. Paul Peter Taks comments Couldnt have said it any better I think this is a table pounding buy opportunity. https://t.co/bPy3nr48tD $CADL Dr. Paul Peter Taks comments Couldnt have said it any better I think this is a table pounding buy opportunity. https://t.co/bPy3nr48tD"
X Link 2025-08-12T01:36Z [---] followers, [---] engagements
"@fbjb816 $CATX"
X Link 2025-08-23T11:13Z [---] followers, [--] engagements
"$CADL @CandelTx .@paulpetertak @CandelTx discusses the company's viral immunotherapy for brain cancer how it works and what clinical studies have shown to date. @GlobalGenes #RARECast https://t.co/DsMOSFXLZf https://t.co/kBM3QDD0ut .@paulpetertak @CandelTx discusses the company's viral immunotherapy for brain cancer how it works and what clinical studies have shown to date. @GlobalGenes #RARECast https://t.co/DsMOSFXLZf https://t.co/kBM3QDD0ut"
X Link 2025-09-20T00:29Z [---] followers, [---] engagements
"$CADL Did you that CAN-2409 has SPA Fast Track and RMAT from FDA for Prostate cancer @CandelTx https://www.pharmanow.live/latest-news/fda-rmat-designation-can-2409 https://www.pharmanow.live/latest-news/fda-rmat-designation-can-2409"
X Link 2025-10-04T11:00Z [---] followers, [---] engagements
"$CADL https://ir.candeltx.com/news-releases/news-release-details/candel-therapeutics-host-virtual-rd-event-december-5-2025 https://ir.candeltx.com/news-releases/news-release-details/candel-therapeutics-host-virtual-rd-event-december-5-2025"
X Link 2025-11-18T00:05Z [---] followers, [---] engagements
"@Maximus_Holla $CATX"
X Link 2025-11-21T22:47Z [---] followers, [---] engagements
"@Pharmdca $cadl"
X Link 2025-12-26T03:38Z [---] followers, [---] engagements
"@StockMKTNewz $CADL"
X Link 2025-12-31T18:01Z [---] followers, [---] engagements
"Blackrock 5.2% stake $CADL @CandelTx #ICYMI - Our Virtual R&D Day brought together immunotherapy legends alongside leading oncologists to discuss our viral immunotherapy platform CAN-2409s path to BLA submission and updates across our clinical pipeline. Watch the full webcast https://t.co/BOauAYuC0J $CADL https://t.co/WPJNefgDuZ #ICYMI - Our Virtual R&D Day brought together immunotherapy legends alongside leading oncologists to discuss our viral immunotherapy platform CAN-2409s path to BLA submission and updates across our clinical pipeline. Watch the full webcast https://t.co/BOauAYuC0J"
X Link 2026-01-21T17:55Z [---] followers, [---] engagements
"@DanW2Capital https://ir.candeltx.com/news-releases/news-release-details/candel-therapeutics-host-virtual-rd-event-december-5-2025 https://ir.candeltx.com/news-releases/news-release-details/candel-therapeutics-host-virtual-rd-event-december-5-2025"
X Link 2025-11-18T00:05Z [---] followers, [--] engagements
"$CADL Candel Therapeutics Isnt Just a Science Fair Anymore @CandelTx $CADL Candel Therapeutics Inc. (NASDAQ:CADL) is one of those small-caps that can flip the narrative fastbecause its not pitching theory. Its lead program has reported Phase [--] prostate cancer results with a statistically significant endpoint win and the company is pointing to $CADL Candel Therapeutics Inc. (NASDAQ:CADL) is one of those small-caps that can flip the narrative fastbecause its not pitching theory. Its lead program has reported Phase [--] prostate cancer results with a statistically significant endpoint win and the"
X Link 2026-02-14T19:28Z [---] followers, [--] engagements
"$CADL Candel Therapeutics Isnt Just a Science Fair Anymore @CandelTx $CADL Candel Therapeutics Inc. (NASDAQ:CADL) is one of those small-caps that can flip the narrative fastbecause its not pitching theory. Its lead program has reported Phase [--] prostate cancer results with a statistically significant endpoint win and the company is pointing to $CADL Candel Therapeutics Inc. (NASDAQ:CADL) is one of those small-caps that can flip the narrative fastbecause its not pitching theory. Its lead program has reported Phase [--] prostate cancer results with a statistically significant endpoint win and the"
X Link 2026-02-14T19:28Z [---] followers, [--] engagements
"$CADL Candel Therapeutics Inc. (NASDAQ:CADL) is one of those small-caps that can flip the narrative fastbecause its not pitching theory. Its lead program has reported Phase [--] prostate cancer results with a statistically significant endpoint win and the company is pointing to a clear regulatory runway that investors can actually calendar. https://biotechhealthx.com/biotech-news/the-290m-cancer-biotech-with-phase-3-proof-candel-cadls-viral-immunotherapy-isnt-just-a-science-fair-anymore/"
X Link 2026-02-14T04:32Z [---] followers, [---] engagements
"Blackrock 5.2% stake $CADL @CandelTx #ICYMI - Our Virtual R&D Day brought together immunotherapy legends alongside leading oncologists to discuss our viral immunotherapy platform CAN-2409s path to BLA submission and updates across our clinical pipeline. Watch the full webcast https://t.co/BOauAYuC0J $CADL https://t.co/WPJNefgDuZ #ICYMI - Our Virtual R&D Day brought together immunotherapy legends alongside leading oncologists to discuss our viral immunotherapy platform CAN-2409s path to BLA submission and updates across our clinical pipeline. Watch the full webcast https://t.co/BOauAYuC0J"
X Link 2026-01-21T17:55Z [---] followers, [---] engagements
"#ICYMI - Our Virtual R&D Day brought together immunotherapy legends alongside leading oncologists to discuss our viral immunotherapy platform CAN-2409s path to BLA submission and updates across our clinical pipeline. Watch the full webcast $CADL https://ir.candeltx.com/events/event-details/candel-therapeutics-host-virtual-rd-event https://ir.candeltx.com/events/event-details/candel-therapeutics-host-virtual-rd-event"
X Link 2026-01-21T15:00Z [---] followers, [----] engagements
"Should be $10 by EOY $CATX Target price: $2.70 Perspective Therapeutics Inc. is a medical technology and radiopharmaceutical company which engages in the provision of treatment applications for cancers. https://t.co/kMv7qvH62A $CATX Target price: $2.70 Perspective Therapeutics Inc. is a medical technology and radiopharmaceutical company which engages in the provision of treatment applications for cancers. https://t.co/kMv7qvH62A"
X Link 2026-01-03T12:21Z [---] followers, [--] engagements
"$CATX Target price: $2.70 Perspective Therapeutics Inc. is a medical technology and radiopharmaceutical company which engages in the provision of treatment applications for cancers"
X Link 2025-11-25T13:31Z [----] followers, [----] engagements
"$CADL https://ir.candeltx.com/news-releases/news-release-details/candel-therapeutics-host-virtual-rd-event-december-5-2025 https://ir.candeltx.com/news-releases/news-release-details/candel-therapeutics-host-virtual-rd-event-december-5-2025"
X Link 2025-11-18T00:05Z [---] followers, [---] engagements
"$CADL Did you that CAN-2409 has SPA Fast Track and RMAT from FDA for Prostate cancer @CandelTx https://www.pharmanow.live/latest-news/fda-rmat-designation-can-2409 https://www.pharmanow.live/latest-news/fda-rmat-designation-can-2409"
X Link 2025-10-04T11:00Z [---] followers, [---] engagements
"$CADL @CandelTx .@paulpetertak @CandelTx discusses the company's viral immunotherapy for brain cancer how it works and what clinical studies have shown to date. @GlobalGenes #RARECast https://t.co/DsMOSFXLZf https://t.co/kBM3QDD0ut .@paulpetertak @CandelTx discusses the company's viral immunotherapy for brain cancer how it works and what clinical studies have shown to date. @GlobalGenes #RARECast https://t.co/DsMOSFXLZf https://t.co/kBM3QDD0ut"
X Link 2025-09-20T00:29Z [---] followers, [---] engagements
".@paulpetertak @CandelTx discusses the company's viral immunotherapy for brain cancer how it works and what clinical studies have shown to date. @GlobalGenes #RARECast https://globalgenes.org/raredaily/650370/ https://globalgenes.org/raredaily/650370/"
X Link 2025-09-19T18:38Z [----] followers, [----] engagements
"RT @paulpetertak: I really appreciate your response @JacobPlieth. Debating helps in the context of truth-seeking and X is a good platform"
X Link 2025-09-12T22:18Z [---] followers, [--] engagements
"I really appreciate your response @JacobPlieth. Debating helps in the context of truth-seeking and X is a good platform to do so. Engaging in constructive debate is great and I want to thank you for this. Moving forward I will be happy to answer any questions and provide context before you publish your own independent views based on the facts provided. In fact I am looking forward to working with you. Based on the specific points you made earlier this week for example about the validity of the SPA and the lack of ITT analysis (both comments were erroneous) it appeared that these were"
X Link 2025-09-12T12:27Z [----] followers, [----] engagements
""The comments about the SPA are also completely wrong and misleading as Candel has strictly adhered to the agreement with the FDA and the SPA is intact" From $CADL [--] Nov [----] SEC filing (8/8)"
X Link 2025-09-11T11:20Z 31.8K followers, [----] engagements
"Impressive to get so many things wrong in one report by Jacob Plieth from @ApexOnco . [--]. The name of CAN-2409 is aglatimagene besadenovec not agla-vec. [--]. The data of the phase 2a clinical trial of CAN-240 in NSCLC has never disappointed. They are in fact very encouraging reason why the presentation by Professor Charu Aggarwal was selected for oral presentation at World Lung [----] and why Candel recently had a very constructive end of phase [--] meeting with the FDA. This data also resulted in Fast Track Designation from the FDA; the promising overall survival data got even stronger after"
X Link 2025-09-10T21:49Z [----] followers, 13.9K engagements
": @WilliamBlair Senior Biotech Analyst Andy Hsieh reacts to today's oral obesity data from Viking's VK2735 and recent data from Lilly's orforglipron. $VKTX $LLY Full video: https://www.biotechtv.com/post/andy-hsieh-vk2735-august-19-2025 https://www.biotechtv.com/post/andy-hsieh-vk2735-august-19-2025"
X Link 2025-08-19T21:26Z 10.7K followers, 68.5K engagements
"$CADL indeed a table pounding buy opportunity $CADL Dr. Paul Peter Taks comments Couldnt have said it any better I think this is a table pounding buy opportunity. https://t.co/bPy3nr48tD $CADL Dr. Paul Peter Taks comments Couldnt have said it any better I think this is a table pounding buy opportunity. https://t.co/bPy3nr48tD"
X Link 2025-08-12T01:36Z [---] followers, [---] engagements
"$CADL Dr. Paul Peter Taks comments Couldnt have said it any better I think this is a table pounding buy opportunity"
X Link 2025-07-15T00:16Z [---] followers, [----] engagements
"$CADL @CandelTx $CADL appears significantly undervalued. Management recently bought $7.1 million of stock. Its lead asset achieved statistically significant Phase [--] results under an FDA SPA in a $10 billion market and was highlighted at ASCO. Cash runway extends to Q1 [----]. Two additional $CADL appears significantly undervalued. Management recently bought $7.1 million of stock. Its lead asset achieved statistically significant Phase [--] results under an FDA SPA in a $10 billion market and was highlighted at ASCO. Cash runway extends to Q1 [----]. Two additional"
X Link 2025-07-26T15:35Z [---] followers, [---] engagements
"$CADL appears significantly undervalued. Management recently bought $7.1 million of stock. Its lead asset achieved statistically significant Phase [--] results under an FDA SPA in a $10 billion market and was highlighted at ASCO. Cash runway extends to Q1 [----]. Two additional programs are moving toward Phase [--] with non-dilutive funding. A grant-backed rHGG asset has promising data due later this year. Analyst price targets cluster around $20 $25 per share. What an opportunity"
X Link 2025-07-14T22:04Z [----] followers, [----] engagements
": @CandelTx's CEO @paulpetertak describes phase [--] prostate cancer data from the company's off-the-shelf adeno delivered cancer immunotherapy. #ASCO25 $CADL Full video: https://www.biotechtv.com/post/candel-therapeutics-asco-2025 https://www.biotechtv.com/post/candel-therapeutics-asco-2025"
X Link 2025-06-02T23:55Z 10.7K followers, [----] engagements
"$CADL https://www.biotechtv.com/post/the-studio-at-kendall-square-paul-peter-tak-mike-rea https://www.biotechtv.com/post/the-studio-at-kendall-square-paul-peter-tak-mike-rea"
X Link 2025-04-02T02:08Z [---] followers, [---] engagements
"We're pleased to share recent coverage highlighting our phase 2b and phase [--] prostate cancer clinical trials and anticipated data readouts. These trials represent key milestones as we advance novel treatments for cancer patients. $CADL https://www.proactiveinvestors.com/companies/news/1061802/candel-therapeutics-is-pushing-for-a-paradigm-shift-in-cancer-treatment-1061802.html https://www.proactiveinvestors.com/companies/news/1061802/candel-therapeutics-is-pushing-for-a-paradigm-shift-in-cancer-treatment-1061802.html"
X Link 2024-12-06T16:00Z [---] followers, [----] engagements
"Join me in NC State Day of Giving [----] https://dayofgiving.ncsu.edu https://dayofgiving.ncsu.edu"
X Link 2024-03-21T02:11Z [---] followers, [---] engagements
"RT @elonmusk: While it is trivial to enter the United States illegally it is insanely difficult for legal immigrants to move to the United"
X Link 2024-01-05T00:55Z [---] followers, 26.8K engagements
"While it is trivial to enter the United States illegally it is insanely difficult for legal immigrants to move to the United States. This is madness We should shut down illegal immigration and greatly increase legal immigration. This chart should make you go insane. This is the number of high skilled workers that want to work here. There is a cap at [-----] slots that will be filled. We are actively shooting our future selves in the foot. https://t.co/kYA8BDhzHC This chart should make you go insane. This is the number of high skilled workers that want to work here. There is a cap at [-----] slots"
X Link 2024-01-04T17:41Z 234.7M followers, 23.8M engagements
"This chart should make you go insane. This is the number of high skilled workers that want to work here. There is a cap at [-----] slots that will be filled. We are actively shooting our future selves in the foot"
X Link 2024-01-04T16:28Z 2.5M followers, 22.4M engagements
"Join me in #GivingPack https://dayofgiving.ncsu.edu https://dayofgiving.ncsu.edu"
X Link 2022-03-23T14:33Z [---] followers, [--] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing